Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine

Cadila Healthcare enters pact with Shilpa Medicare for production of ZyCoV-D vaccine

PTIUpdated: Friday, September 24, 2021, 03:55 PM IST
article-image
Shares of Cadila Healthcare were trading at Rs 564.30 per scrip on BSE, down 0.46% from its previous close/ Representational image | Photo credit: PTI

Drug firm Cadila Healthcare on Friday said it has entered into an agreement with Shilpa Medicare for the production of its COVID-19 vaccine, ZyCoV-D.

The company has, "entered into a definitive agreement with Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals for production-supply of the ZyCoV-D vaccine drug substance from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka," Cadila Healthcare said in a regulatory filing.

The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties, it added.

"The company will transfer the ZyCoV-D technology to Shilpa Biologicals Pvt Ltd (SBPL). Under the agreement, SBPL will be responsible for manufacture of the drug substance of the vaccine, while the company is responsible for filling / packaging / distribution / marketing of the vaccine in its marketing territories," Cadila Healthcare said.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, it added.

The vaccine was granted the Emergency Use Authorisation (EUA) by the Indian drug regulator on August 20.

Shares of Cadila Healthcare were trading at Rs 564.30 per scrip on BSE, down 0.46 per cent from its previous close.

RECENT STORIES

Divorce Disputes Spill Over To Board Room: Nawaz Modi Alleges Gautam Singhania; Uses Personal...

Divorce Disputes Spill Over To Board Room: Nawaz Modi Alleges Gautam Singhania; Uses Personal...

Meta Shares Crash Over 10% As Anxiety Over Success Of AI Surges

Meta Shares Crash Over 10% As Anxiety Over Success Of AI Surges

Land Rover Defender Octa: Most Powerful Version Set to Debut on July 3rd

Land Rover Defender Octa: Most Powerful Version Set to Debut on July 3rd

UK-TIK TOK Ban: How Other Countries are Restricting it

UK-TIK TOK Ban: How Other Countries are Restricting it

Shriram Finance Q4 Results Announces a 150% Dividend, 450% Dividend in a Year

Shriram Finance Q4 Results Announces a 150% Dividend, 450% Dividend in a Year